ALKS-3831

Alkermes is handed a CRL for ‘3831, marking another setback on the R&D front
Endpoints
Tue, 11/17/20 - 10:48 am
Alkermes
ALKS-3831
FDA
CRL
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Alkermes Schizophrenia Drug Heads To FDA, But Questions Linger
Xconomy
Thu, 11/29/18 - 09:37 am
ALKS-3831
Alkermes
schizophrenia
FDA